We therefore hypothesized that DEK might be a molecular bridge between synaptic homeostasis and tau proteostasis, and that, like at early stages of AD, Dek-silenced neurons might have elevated tau in addition to electrophysiological abnormalities. The gene discussed is MAPT; the disease is Alzheimer disease.